Transgenic mice, which express the AA 15-lipoxygenating human ALOX15 under the control of the lysozyme promoter (macrophage specific expression) in addition to the endogenous AA 12-lipoxygenating mouse Alox15, are protected from arterial lipid deposition in a mouse atherosclerosis model. Here, LYZ is linked to atherosclerosis.